Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid-Reference-Cited by-同舟云学术

Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid

Published:2008-11 Issue:3 Volume:107 Page:701-711
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:

Author:

Alvarez-Fischer Daniel,Guerreiro Serge,Hunot Stéphane,Saurini Françoise,Marien Marc,Sokoloff Pierre,Hirsch Etienne C.,Hartmann Andreas,Michel Patrick P.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1471-4159.2008.05651.x/fullpdf

Reference36 articles.

1. Parkinson’s disease: pathophysiology;Agid;Lancet,1991

2. Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure;Barcia;Glia,2004

3. Parkinson’s disease: mechanisms and models;Dauer;Neuron.,2003

4. Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson’s disease;Dervan;Exp. Neurol.,2004

5. Marmoset monkey models of Parkinson’s disease: which model, when and why?;Eslamboli;Brain Res. Bull.,2005

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies;Metabolites;2024-06-22

2. Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission;npj Parkinson's Disease;2024-02-17

3. Parkinson’s Disease: Exploring Different Animal Model Systems;International Journal of Molecular Sciences;2023-05-22

4. Selecting the Best Animal Model of Parkinson’s Disease for Your Research Purpose: Insight from in vivo PET Imaging Studies;Current Neuropharmacology;2023-05

5. MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modeling of Parkinson’s Disease;Handbook of Neurotoxicity;2022